Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas

Neuroendocrinology

Volumn 82, Issue 3-4, 2005, Pages 208-214

  Giorgi, R R ^a   Correa Giannella, M L C ^a   Casarini, A P M ^a   Machado, M C ^a   Bronstein, M D ^a   Cescato, V A ^a   Giannella Neto, D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Corticotropin molecular neuroendocrinology; Metallothioneins; Pituitary adenoma

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; ISOPROTEIN; MESSENGER RNA; METALLOTHIONEIN III; PROLACTIN; TRANSCRIPTION FACTOR; ZINC;

ADULT; ARTICLE; CANCER GENETICS; CARCINOMA; CELL LINEAGE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC DATABASE; HORMONE RELEASE; HUMAN; HUMAN GENOME; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MALE; MICROARRAY ANALYSIS; MT3 GENE; NONFUNCTIONAL PITUITARY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA GENE; SPINAL CORD METASTASIS;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; GENE EXPRESSION; HUMAN GROWTH HORMONE; HUMANS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PITUITARY NEOPLASMS; PROLACTIN; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD NEOPLASMS;

EID: 33646521484     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092521     Document Type: Article

References (23)

1. Klibanski A, Zervas NT: Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 1991;324:822-831.
2. Imboden PN, Borruat FX, De Tribolet N, Meagher-Villemure K, Pica A, Gomez F: Nonfunctioning pituitary carcinoma. Pituitary 2005;7:149-156.
3. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM: Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 2005;65:10214-10222.
4. Qian X, Scheithauer BW, Kovacs K, Lloyd RV: DNA microarrays: recent developments and applications to the study of pituitary tissues. Endocrine 2005;28:49-56.
5. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM: Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2001;86:3097-3107.
6. Morris DG, Musat M, Czirjak S, Hanzely Z, Lillington DM, Korbonits M, Grossman AB: Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 2005;153:143-151.
7. Chen H, Huang XN, Stewart AF, Sepulveda JL: Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiol Genom 2004;18:273-283.
8. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR: MAPP-Finder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003;4:R7.
9. ΔΔCt. Methods 2001;25:402-408.
10. Cherian MG, Howell SB, Imura N, Klaassen CD, Koropatnick J, Lazo JS, Waalkers MP: Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol 1994;126:1-5.
11. Barnes NL, Ackland ML, Cornish EJ: Metallothionein isoform expression by breast cancer cells. Int J Biochem Cell Biol 2000;32:895-903.
12. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T: Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease EMBO J 1992;11:4843-4850.
13. Uchida Y: Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases. Biol Signals 1994;3:211-215.
14. Uchida Y, Gomi F, Masumizu T, Miura Y: Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J Biol Chem 2002;277:32353-32359.
15. Burdette SC, Lippard SJ: Meeting of the minds: metalloneurochemistry. Proc Natl Acad Sci USA 2003;100:3605-3610.
16. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, Szeto DP, Hooshmand F, Aggarwal AK, Rosenfeld MG: Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 1999;97:587-598.
17. Claus Jacob, Wolfgang Maret, Bert L: Vallee: control of zinc transfer between thionein, metallothionein, and zinc proteins. PNAS 1998;95:3489-3494.
18. Reaves SK, Fanzo JC, Arima K, Wu JY, Wang YR, Lei KY: Expression of the p53 tumor suppressor gene is up-regulated by depletion of intracellular zinc in HepG2 cells. J Nutr 2000;130:1688-1694.
19. Deng D, El-Rifai W, Ji J, Zhu B, Trampont P, Li J, Smith MF, Powel SM: Hypermethylation of metallothionein-3 CpG island in gastric carcinoma. Carcinogenesis 2003;24:25-29.
20. Smith E, Drew PA, Tian ZQ, Mayne GC, De Young NJ, Ruszkiewicz A, Liu JF, Watson DI, Jamieson GG: Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol Cancer 2005;4:42.
21. Cherian MG, Juyasurya A, Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 2003;533:201-209.
22. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428.
23. Zhang B, Satoh M, Nishimura N, Suzuki JS, Sone H, Aoki Y, Tohyama C: Metallothionein deficiency promotes mouse skin carcinogenesis induced by 7,12-dimethylbenz [a] anthracene. Cancer Res 1988;58:4044-4046.